PIM1, a serine/threonine protein kinase, can directly bind to CXCR4 and facilitate its membranous expression, whereas the elevated co-expression of these two proteins, PIM1 and CXCR4, was correlated with aggressiveness and poor prognosis in prostate cancer patients. This evidence concerns the gene CXCR4 and prostate cancer.